Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Haffner

Showing results (61-70 of 327) with videos related to

Pageof 33
Sort By:
Diabetes, Obesity & Metabolism|January 25, 2012
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysisM Pendergrass, C Fenton, S M Haffner, et al.
Metabolism: Clinical and Experimental|October 1, 1987
The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterolD Applebaum-Bowden, S M Haffner, W R Hazzard
Diabetes Care|April 1, 1991
Decrease of lipoprotein(a) with improved glycemic control in IDDM subjectsS M Haffner, K R Tuttle, D L Rainwater
Endocrine Research|January 1, 1990
The relationship of insulin sensitivity and metabolic clearance of insulin to adiposity and sex hormone binding globulinS M Haffner, M S Katz, J F Dunn
Metabolism: Clinical and Experimental|March 1, 1992
Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 patternS M Haffner, R S Kushwaha, W R Hazzard
Diabetologia|July 1, 1997
Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes StudyS M Haffner, C Gonzalez, L Mykkänen, et al.
Diabetes|February 1, 1994
Insulin resistance, body fat distribution, and sex hormones in menS M Haffner, P Karhapää, L Mykkänen, et al.
European Journal of Clinical Investigation|October 1, 1989
Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia)S M Haffner, R S Kushwaha, W R Hazzard
Metabolism: Clinical and Experimental|March 1, 1992
Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal womenS M Haffner, J F Dunn, M S Katz
Epidemiologic Reviews|January 27, 1999
Development of the multiple metabolic syndrome: an epidemiologic perspectiveA D Liese, E J Mayer-Davis, S M Haffner
Pageof 33

Showing results (61-70 of 327) with videos related to

Sort By:
Pageof 33
Diabetes, Obesity & Metabolism|January 25, 2012
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysisM Pendergrass, C Fenton, S M Haffner, et al.
Metabolism: Clinical and Experimental|October 1, 1987
The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterolD Applebaum-Bowden, S M Haffner, W R Hazzard
Diabetes Care|April 1, 1991
Decrease of lipoprotein(a) with improved glycemic control in IDDM subjectsS M Haffner, K R Tuttle, D L Rainwater
Endocrine Research|January 1, 1990
The relationship of insulin sensitivity and metabolic clearance of insulin to adiposity and sex hormone binding globulinS M Haffner, M S Katz, J F Dunn
Metabolism: Clinical and Experimental|March 1, 1992
Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 patternS M Haffner, R S Kushwaha, W R Hazzard
Diabetologia|July 1, 1997
Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes StudyS M Haffner, C Gonzalez, L Mykkänen, et al.
Diabetes|February 1, 1994
Insulin resistance, body fat distribution, and sex hormones in menS M Haffner, P Karhapää, L Mykkänen, et al.
European Journal of Clinical Investigation|October 1, 1989
Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia)S M Haffner, R S Kushwaha, W R Hazzard
Metabolism: Clinical and Experimental|March 1, 1992
Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal womenS M Haffner, J F Dunn, M S Katz
Epidemiologic Reviews|January 27, 1999
Development of the multiple metabolic syndrome: an epidemiologic perspectiveA D Liese, E J Mayer-Davis, S M Haffner
Pageof 33